Precision System Science（7707）株式概要プレシジョンシステムサイエンス株式会社は、その子会社とともに、日本国内において、自動化システム／機器、その他の理化学機器、ソフトウェア、その他の製品の開発、製造、販売を行っている。 詳細7707 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績2/6財務の健全性5/6配当金0/6報酬今年は黒字化を達成 リスク分析JP市場と比較して、過去 3 か月間の株価の変動が非常に大きい意味のある時価総額がありません ( ¥7B )財務結果に影響を与える大きな一時的項目 すべてのリスクチェックを見る7707 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥249.00255.2% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-1b9b2016201920222025202620282031Revenue JP¥2.0bEarnings JP¥52.5mAdvancedSet Fair ValueView all narrativesPrecision System Science Co., Ltd. 競合他社CellSourceSymbol: TSE:4880Market cap: JP¥7.0bWDB cocoSymbol: TSE:7079Market cap: JP¥6.2bImmuno-Biological LaboratoriesSymbol: TSE:4570Market cap: JP¥11.0bHuman Metabolome TechnologiesSymbol: TSE:6090Market cap: JP¥3.6b価格と性能株価の高値、安値、推移の概要Precision System Science過去の株価現在の株価JP¥249.0052週高値JP¥299.0052週安値JP¥175.00ベータ0.581ヶ月の変化6.87%3ヶ月変化12.16%1年変化21.46%3年間の変化-28.24%5年間の変化-70.32%IPOからの変化-89.54%最新ニュースReported Earnings • May 20Third quarter 2026 earnings released: EPS: JP¥5.10 (vs JP¥1.09 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.10 (up from JP¥1.09 loss in 3Q 2025). Revenue: JP¥1.24b (down 1.7% from 3Q 2025). Net income: JP¥140.0m (up JP¥170.0m from 3Q 2025). Profit margin: 11% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 18Second quarter 2026 earnings released: EPS: JP¥0.26 (vs JP¥2.79 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥0.26 (up from JP¥2.79 loss in 2Q 2025). Revenue: JP¥1.22b (up 8.8% from 2Q 2025). Net income: JP¥7.00m (up JP¥84.0m from 2Q 2025). Profit margin: 0.6% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.New Risk • Feb 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 47% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.3% average weekly change). Market cap is less than US$100m (JP¥6.17b market cap, or US$39.9m).分析記事 • Jan 08Improved Revenues Required Before Precision System Science Co., Ltd. (TSE:7707) Shares Find Their FeetWith a price-to-sales (or "P/S") ratio of 1.2x Precision System Science Co., Ltd. ( TSE:7707 ) may be sending bullish...お知らせ • Dec 03Precision System Science Co., Ltd. to Report Q3, 2026 Results on May 15, 2026Precision System Science Co., Ltd. announced that they will report Q3, 2026 results on May 15, 2026お知らせ • Dec 02Precision System Science Co., Ltd. to Report Q2, 2026 Results on Feb 16, 2026Precision System Science Co., Ltd. announced that they will report Q2, 2026 results on Feb 16, 2026最新情報をもっと見るRecent updatesReported Earnings • May 20Third quarter 2026 earnings released: EPS: JP¥5.10 (vs JP¥1.09 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.10 (up from JP¥1.09 loss in 3Q 2025). Revenue: JP¥1.24b (down 1.7% from 3Q 2025). Net income: JP¥140.0m (up JP¥170.0m from 3Q 2025). Profit margin: 11% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 18Second quarter 2026 earnings released: EPS: JP¥0.26 (vs JP¥2.79 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥0.26 (up from JP¥2.79 loss in 2Q 2025). Revenue: JP¥1.22b (up 8.8% from 2Q 2025). Net income: JP¥7.00m (up JP¥84.0m from 2Q 2025). Profit margin: 0.6% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.New Risk • Feb 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 47% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.3% average weekly change). Market cap is less than US$100m (JP¥6.17b market cap, or US$39.9m).分析記事 • Jan 08Improved Revenues Required Before Precision System Science Co., Ltd. (TSE:7707) Shares Find Their FeetWith a price-to-sales (or "P/S") ratio of 1.2x Precision System Science Co., Ltd. ( TSE:7707 ) may be sending bullish...お知らせ • Dec 03Precision System Science Co., Ltd. to Report Q3, 2026 Results on May 15, 2026Precision System Science Co., Ltd. announced that they will report Q3, 2026 results on May 15, 2026お知らせ • Dec 02Precision System Science Co., Ltd. to Report Q2, 2026 Results on Feb 16, 2026Precision System Science Co., Ltd. announced that they will report Q2, 2026 results on Feb 16, 2026お知らせ • Oct 17Precision System Science Co., Ltd. to Report Q1, 2026 Results on Nov 14, 2025Precision System Science Co., Ltd. announced that they will report Q1, 2026 results on Nov 14, 2025Reported Earnings • Oct 04Full year 2025 earnings released: JP¥9.20 loss per share (vs JP¥40.57 loss in FY 2024)Full year 2025 results: JP¥9.20 loss per share (improved from JP¥40.57 loss in FY 2024). Revenue: JP¥4.69b (up 18% from FY 2024). Net loss: JP¥253.0m (loss narrowed 77% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.Reported Earnings • Aug 16Full year 2025 earnings released: JP¥9.20 loss per share (vs JP¥40.57 loss in FY 2024)Full year 2025 results: JP¥9.20 loss per share (improved from JP¥40.57 loss in FY 2024). Revenue: JP¥4.69b (up 18% from FY 2024). Net loss: JP¥253.0m (loss narrowed 77% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 27% per year, which means it is performing significantly worse than earnings.お知らせ • Aug 14Precision System Science Co., Ltd., Annual General Meeting, Sep 26, 2025Precision System Science Co., Ltd., Annual General Meeting, Sep 26, 2025.お知らせ • Jun 29Precision System Science Co., Ltd. to Report Fiscal Year 2025 Results on Aug 14, 2025Precision System Science Co., Ltd. announced that they will report fiscal year 2025 results on Aug 14, 2025Reported Earnings • May 21Third quarter 2025 earnings released: JP¥1.09 loss per share (vs JP¥2.53 profit in 3Q 2024)Third quarter 2025 results: JP¥1.09 loss per share (down from JP¥2.53 profit in 3Q 2024). Revenue: JP¥1.27b (up 36% from 3Q 2024). Net loss: JP¥30.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.分析記事 • Apr 07Precision System Science Co., Ltd.'s (TSE:7707) 30% Dip In Price Shows Sentiment Is Matching RevenuesThe Precision System Science Co., Ltd. ( TSE:7707 ) share price has fared very poorly over the last month, falling by a...お知らせ • Mar 07Precision System Science Co., Ltd. (TSE:7707) announces an Equity Buyback for 440,600 shares, for ¥100.46 million.Precision System Science Co., Ltd. (TSE:7707) announces a share repurchase program. Under the program, the company will repurchase up to 440,600 shares of its issued shares for a total of ¥100.46 million. The shares will be repurchased at a purchase price of ¥228 per share. The purpose of the program is to enhance shareholder returns and improve capital efficiency.お知らせ • Mar 01Precision System Science Co., Ltd. to Report Q3, 2025 Results on May 15, 2025Precision System Science Co., Ltd. announced that they will report Q3, 2025 results on May 15, 2025Reported Earnings • Feb 16Second quarter 2025 earnings released: JP¥2.79 loss per share (vs JP¥18.46 loss in 2Q 2024)Second quarter 2025 results: JP¥2.79 loss per share (improved from JP¥18.46 loss in 2Q 2024). Revenue: JP¥1.12b (up 19% from 2Q 2024). Net loss: JP¥77.0m (loss narrowed 85% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance.お知らせ • Dec 14Precision System Science Co., Ltd. to Report Q2, 2025 Results on Feb 14, 2025Precision System Science Co., Ltd. announced that they will report Q2, 2025 results on Feb 14, 2025分析記事 • Nov 25Does Precision System Science (TSE:7707) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Reported Earnings • Oct 03Full year 2024 earnings released: JP¥40.57 loss per share (vs JP¥47.92 loss in FY 2023)Full year 2024 results: JP¥40.57 loss per share (improved from JP¥47.92 loss in FY 2023). Revenue: JP¥3.98b (down 25% from FY 2023). Net loss: JP¥1.12b (loss narrowed 15% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.分析記事 • Sep 04Optimistic Investors Push Precision System Science Co., Ltd. (TSE:7707) Shares Up 111% But Growth Is LackingPrecision System Science Co., Ltd. ( TSE:7707 ) shares have had a really impressive month, gaining 111% after a shaky...お知らせ • Sep 04Precision System Science Co., Ltd. to Report Q1, 2025 Results on Nov 14, 2024Precision System Science Co., Ltd. announced that they will report Q1, 2025 results on Nov 14, 2024Reported Earnings • Aug 19Full year 2024 earnings released: JP¥40.57 loss per share (vs JP¥47.92 loss in FY 2023)Full year 2024 results: JP¥40.57 loss per share (improved from JP¥47.92 loss in FY 2023). Revenue: JP¥3.98b (down 25% from FY 2023). Net loss: JP¥1.12b (loss narrowed 15% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.お知らせ • Aug 15Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. (TSE:7707) for ¥60 million.Shuji Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. (TSE:7707) for ¥60 million on August 14, 2024. A cash consideration of ¥60 million will be paid by the buyer. As part of consideration, ¥60 million is paid towards common equity of Universal Bio Research Co., Ltd. For the period ending June 30, 2024, Universal Bio Research Co., Ltd reported total revenue of ¥60.41 million, EBIT of ¥17.4 million and net income of ¥17.17 million. As of June 30, 2024, Universal Bio Research Co., Ltd reported total assets of ¥137.53 million and total common equity of ¥132.54 million. The expected completion of the transaction is December 31, 2024.お知らせ • Aug 14Precision System Science Co., Ltd., Annual General Meeting, Sep 27, 2024Precision System Science Co., Ltd., Annual General Meeting, Sep 27, 2024.分析記事 • Jul 18Precision System Science Co., Ltd. (TSE:7707) Shares Fly 30% But Investors Aren't Buying For GrowthThe Precision System Science Co., Ltd. ( TSE:7707 ) share price has done very well over the last month, posting an...New Risk • Jul 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Earnings have declined by 55% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥6.77b market cap, or US$43.3m).Reported Earnings • May 21Third quarter 2024 earnings released: EPS: JP¥2.53 (vs JP¥6.51 loss in 3Q 2023)Third quarter 2024 results: EPS: JP¥2.53 (up from JP¥6.51 loss in 3Q 2023). Revenue: JP¥929.0m (down 14% from 3Q 2023). Net income: JP¥70.0m (up JP¥250.0m from 3Q 2023). Profit margin: 7.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.お知らせ • Mar 02Precision System Science Co., Ltd. to Report Q3, 2024 Results on May 15, 2024Precision System Science Co., Ltd. announced that they will report Q3, 2024 results on May 15, 2024Reported Earnings • Feb 18Second quarter 2024 earnings released: JP¥18.46 loss per share (vs JP¥6.44 loss in 2Q 2023)Second quarter 2024 results: JP¥18.46 loss per share (further deteriorated from JP¥6.44 loss in 2Q 2023). Revenue: JP¥940.0m (down 41% from 2Q 2023). Net loss: JP¥510.0m (loss widened 187% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.New Risk • Feb 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Market cap is less than US$100m (JP¥5.28b market cap, or US$35.2m).お知らせ • Dec 08Precision System Science Co., Ltd. to Report Q2, 2024 Results on Feb 13, 2024Precision System Science Co., Ltd. announced that they will report Q2, 2024 results on Feb 13, 2024Reported Earnings • Nov 18First quarter 2024 earnings released: JP¥7.85 loss per share (vs JP¥10.42 loss in 1Q 2023)First quarter 2024 results: JP¥7.85 loss per share (improved from JP¥10.42 loss in 1Q 2023). Revenue: JP¥1.07b (down 30% from 1Q 2023). Net loss: JP¥217.0m (loss narrowed 25% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.お知らせ • Sep 24Precision System Science Co., Ltd. to Report Q1, 2024 Results on Nov 14, 2023Precision System Science Co., Ltd. announced that they will report Q1, 2024 results on Nov 14, 2023New Risk • Aug 16New major risk - Revenue and earnings growthEarnings have declined by 9.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.3% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥8.92b market cap, or US$61.4m).Reported Earnings • Aug 16Full year 2023 earnings released: JP¥47.92 loss per share (vs JP¥1.63 profit in FY 2022)Full year 2023 results: JP¥47.92 loss per share (down from JP¥1.63 profit in FY 2022). Revenue: JP¥5.28b (down 29% from FY 2022). Net loss: JP¥1.32b (down JP¥1.37b from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.Reported Earnings • May 19Third quarter 2023 earnings released: JP¥6.51 loss per share (vs JP¥2.86 loss in 3Q 2022)Third quarter 2023 results: JP¥6.51 loss per share (further deteriorated from JP¥2.86 loss in 3Q 2022). Revenue: JP¥1.08b (down 42% from 3Q 2022). Net loss: JP¥180.0m (loss widened 128% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.Reported Earnings • Feb 15Second quarter 2023 earnings released: JP¥6.44 loss per share (vs JP¥0.80 loss in 2Q 2022)Second quarter 2023 results: JP¥6.44 loss per share (further deteriorated from JP¥0.80 loss in 2Q 2022). Revenue: JP¥1.60b (down 7.2% from 2Q 2022). Net loss: JP¥178.0m (loss widened JP¥156.0m from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Feb 10Precision System Science Co., Ltd. to Report Q2, 2023 Results on Feb 14, 2023Precision System Science Co., Ltd. announced that they will report Q2, 2023 results on Feb 14, 2023Reported Earnings • Nov 16First quarter 2023 earnings released: JP¥10.42 loss per share (vs JP¥3.61 profit in 1Q 2022)First quarter 2023 results: JP¥10.42 loss per share (down from JP¥3.61 profit in 1Q 2022). Revenue: JP¥1.53b (down 18% from 1Q 2022). Net loss: JP¥288.0m (down 388% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Daisuke Ogiwara was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 13First quarter 2023 earnings released: JP¥10.42 loss per share (vs JP¥3.61 profit in 1Q 2022)First quarter 2023 results: JP¥10.42 loss per share (down from JP¥3.61 profit in 1Q 2022). Revenue: JP¥1.53b (down 18% from 1Q 2022). Net loss: JP¥288.0m (down 388% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 06Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: JP¥1.63 (down from JP¥29.21 in FY 2021). Revenue: JP¥7.43b (down 20% from FY 2021). Net income: JP¥45.0m (down 94% from FY 2021). Profit margin: 0.6% (down from 8.6% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 7.1%. Earnings per share (EPS) also missed analyst estimates by 89%. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Sep 28Precision System Science Co., Ltd. to Report Q1, 2023 Results on Nov 11, 2022Precision System Science Co., Ltd. announced that they will report Q1, 2023 results on Nov 11, 2022お知らせ • Aug 14Precision System Science Co., Ltd., Annual General Meeting, Sep 28, 2022Precision System Science Co., Ltd., Annual General Meeting, Sep 28, 2022.Reported Earnings • Aug 14Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: JP¥1.63 (down from JP¥29.21 in FY 2021). Revenue: JP¥7.43b (down 20% from FY 2021). Net income: JP¥45.0m (down 94% from FY 2021). Profit margin: 0.6% (down from 8.6% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 7.1%. Earnings per share (EPS) also missed analyst estimates by 89%. Over the next year, revenue is forecast to grow 12%, compared to a 16% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 01Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to JP¥674, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 19x in the Life Sciences industry in Japan. Total returns to shareholders of 70% over the past three years.Buying Opportunity • Jul 27Now 21% undervaluedOver the last 90 days, the stock is up 63%. The fair value is estimated to be JP¥878, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 12% in 2 years. Earnings is forecast to grow by 92% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 09Investor sentiment improved over the past weekAfter last week's 23% share price gain to JP¥575, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 17x in the Life Sciences industry in Japan. Total returns to shareholders of 41% over the past three years.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 28% share price gain to JP¥463, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 17x in the Life Sciences industry in Japan. Total returns to shareholders of 9.1% over the past three years.お知らせ • Jun 03Precision System Science Co., Ltd. to Report Fiscal Year 2022 Results on Aug 12, 2022Precision System Science Co., Ltd. announced that they will report fiscal year 2022 results on Aug 12, 2022Reported Earnings • May 17Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: JP¥2.86 loss per share (down from JP¥3.87 profit in 3Q 2021). Revenue: JP¥1.87b (down 20% from 3Q 2021). Net loss: JP¥79.0m (down 174% from profit in 3Q 2021). Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 4.2% compared to a 4.4% decline forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Daisuke Ogiwara was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Buying Opportunity • Apr 07Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 3.8%. The fair value is estimated to be JP¥572, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 3.4% in 2 years. Earnings is forecast to grow by 11% in the next 2 years.Price Target Changed • Mar 16Price target decreased to JP¥480Down from JP¥730, the current price target is provided by 1 analyst. New target price is 22% above last closing price of JP¥392. Stock is down 57% over the past year. The company is forecast to post earnings per share of JP¥14.50 for next year compared to JP¥29.21 last year.お知らせ • Feb 27Precision System Science Co., Ltd. to Report Q3, 2022 Results on May 13, 2022Precision System Science Co., Ltd. announced that they will report Q3, 2022 results on May 13, 2022Reported Earnings • Feb 16Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: JP¥0.80 loss per share (down from JP¥5.85 profit in 2Q 2021). Revenue: JP¥1.72b (down 30% from 2Q 2021). Net loss: JP¥22.0m (down 114% from profit in 2Q 2021). Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 7.6% compared to a 1.9% decline forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 16Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to JP¥425, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 41x in the Life Sciences industry in Asia. Total returns to shareholders of 18% over the past three years.Valuation Update With 7 Day Price Move • Jan 28Investor sentiment improved over the past weekAfter last week's 29% share price gain to JP¥575, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 41x in the Life Sciences industry in Asia. Total returns to shareholders of 92% over the past three years.Reported Earnings • Nov 15First quarter 2022 earnings released: EPS JP¥3.61 (vs JP¥7.43 in 1Q 2021)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥1.87b (down 9.9% from 1Q 2021). Net income: JP¥100.0m (down 49% from 1Q 2021). Profit margin: 5.3% (down from 9.4% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.Reported Earnings • Oct 05Full year 2021 earnings released: EPS JP¥29.21 (vs JP¥4.40 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥9.30b (up 84% from FY 2020). Net income: JP¥795.0m (up JP¥909.0m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 123% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥670, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 61x in the Life Sciences industry in Asia. Total returns to shareholders of 53% over the past three years.お知らせ • Aug 14Precision System Science Co., Ltd. (TSE:7707) announces an Equity Buyback for 200,000 shares, representing 0.72% for ¥100 million.Precision System Science Co., Ltd. (TSE:7707) announces a share repurchase program. Under the program, the company will repurchase up to 200,000 shares, representing 0.72% of its issued share capital (excluding treasury stock), at ¥500 per share, for ¥100 million. The purpose of the program is to enhance shareholder returns and to increase the agility of capital policies, and providing incentives for the sustainable improvement of the company's corporate value. The program will run until October 29, 2021. As of June 30, 2021, the company had 27,666,900 shares in issue (excluding treasury stock) and 86 shares in treasury.Reported Earnings • May 17Third quarter 2021 earnings released: EPS JP¥3.87 (vs JP¥0.42 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥2.34b (up 74% from 3Q 2020). Net income: JP¥107.0m (up JP¥96.0m from 3Q 2020). Profit margin: 4.6% (up from 0.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 120% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to JP¥888, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 71.7x. This compares to an average P/E of 41x in the Life Sciences industry in Japan. Total returns to shareholders over the past three years are 51%.Is New 90 Day High Low • Feb 18New 90-day low: JP¥888The company is down 30% from its price of JP¥1,270 on 20 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is up 4.0% over the same period.Reported Earnings • Feb 14Second quarter 2021 earnings released: EPS JP¥5.85 (vs JP¥3.63 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥2.45b (up 121% from 2Q 2020). Net income: JP¥159.0m (up JP¥253.0m from 2Q 2020). Profit margin: 6.5% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 03Precision System Science Co., Ltd. to Report Q2, 2021 Results on Feb 12, 2021Precision System Science Co., Ltd. announced that they will report Q2, 2021 results on Feb 12, 2021Is New 90 Day High Low • Dec 22New 90-day low: JP¥948The company is down 36% from its price of JP¥1,473 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 18% over the same period.Is New 90 Day High Low • Dec 07New 90-day low: JP¥1,050The company is down 33% from its price of JP¥1,571 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 8.0% over the same period.Price Target Changed • Dec 01Price target raised to JP¥660Up from JP¥400, the current price target is provided by 1 analyst. The new target price is 43% below the current share price of JP¥1,168. As of last close, the stock is up 199% over the past year.お知らせ • Oct 10Precision System Science Co., Ltd. to Report Q1, 2021 Results on Nov 13, 2020Precision System Science Co., Ltd. announced that they will report Q1, 2021 results on Nov 13, 2020株主還元7707JP Life SciencesJP 市場7D6.9%-1.8%-3.1%1Y21.5%-7.7%38.2%株主還元を見る業界別リターン: 7707過去 1 年間で-7.7 % の収益を上げたJP Life Sciences業界を上回りました。リターン対市場: 7707は、過去 1 年間で38.2 % のリターンを上げたJP市場を下回りました。価格変動Is 7707's price volatile compared to industry and market?7707 volatility7707 Average Weekly Movement12.3%Life Sciences Industry Average Movement6.2%Market Average Movement5.0%10% most volatile stocks in JP Market9.6%10% least volatile stocks in JP Market2.5%安定した株価: 7707の株価は、 JP市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 7707の weekly volatility ( 12% ) は過去 1 年間安定していますが、依然としてJPの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1985151Yu Sugiyamawww.pss.co.jpプレシジョンシステムサイエンス株式会社は、子会社とともに、日本国内において自動化システム・装置、その他の理化学機器、ソフトウェア等の開発・製造・販売を行っている。また、核酸抽出・生化学検査用抽出試薬geneLEADシリーズ、LecChipシリーズ製品を提供している。また、自動化システム・装置で使用する試薬やプラスチック消耗品の製造・販売も行っている。同社の製品は、遺伝子検査やタンパク質検査を含む体外診断検査市場の研究開発や実用化で使用されている。プレシジョンシステムサイエンス株式会社は1985年に設立され、松戸市に本社を置く。もっと見るPrecision System Science Co., Ltd. 基礎のまとめPrecision System Science の収益と売上を時価総額と比較するとどうか。7707 基礎統計学時価総額JP¥6.84b収益（TTM）JP¥134.00m売上高(TTM)JP¥5.01b51.0xPER（株価収益率1.4xP/Sレシオ7707 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計7707 損益計算書（TTM）収益JP¥5.01b売上原価JP¥3.50b売上総利益JP¥1.51bその他の費用JP¥1.37b収益JP¥134.00m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）4.88グロス・マージン30.07%純利益率2.68%有利子負債／自己資本比率22.7%7707 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 00:58終値2026/05/21 00:00収益2026/03/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Precision System Science Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Kiyokazu YamazakiIchiyoshi Research Institute Inc.Motoya KohtaniNomura Securities Co. Ltd.
Reported Earnings • May 20Third quarter 2026 earnings released: EPS: JP¥5.10 (vs JP¥1.09 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.10 (up from JP¥1.09 loss in 3Q 2025). Revenue: JP¥1.24b (down 1.7% from 3Q 2025). Net income: JP¥140.0m (up JP¥170.0m from 3Q 2025). Profit margin: 11% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 18Second quarter 2026 earnings released: EPS: JP¥0.26 (vs JP¥2.79 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥0.26 (up from JP¥2.79 loss in 2Q 2025). Revenue: JP¥1.22b (up 8.8% from 2Q 2025). Net income: JP¥7.00m (up JP¥84.0m from 2Q 2025). Profit margin: 0.6% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
New Risk • Feb 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 47% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.3% average weekly change). Market cap is less than US$100m (JP¥6.17b market cap, or US$39.9m).
分析記事 • Jan 08Improved Revenues Required Before Precision System Science Co., Ltd. (TSE:7707) Shares Find Their FeetWith a price-to-sales (or "P/S") ratio of 1.2x Precision System Science Co., Ltd. ( TSE:7707 ) may be sending bullish...
お知らせ • Dec 03Precision System Science Co., Ltd. to Report Q3, 2026 Results on May 15, 2026Precision System Science Co., Ltd. announced that they will report Q3, 2026 results on May 15, 2026
お知らせ • Dec 02Precision System Science Co., Ltd. to Report Q2, 2026 Results on Feb 16, 2026Precision System Science Co., Ltd. announced that they will report Q2, 2026 results on Feb 16, 2026
Reported Earnings • May 20Third quarter 2026 earnings released: EPS: JP¥5.10 (vs JP¥1.09 loss in 3Q 2025)Third quarter 2026 results: EPS: JP¥5.10 (up from JP¥1.09 loss in 3Q 2025). Revenue: JP¥1.24b (down 1.7% from 3Q 2025). Net income: JP¥140.0m (up JP¥170.0m from 3Q 2025). Profit margin: 11% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 18Second quarter 2026 earnings released: EPS: JP¥0.26 (vs JP¥2.79 loss in 2Q 2025)Second quarter 2026 results: EPS: JP¥0.26 (up from JP¥2.79 loss in 2Q 2025). Revenue: JP¥1.22b (up 8.8% from 2Q 2025). Net income: JP¥7.00m (up JP¥84.0m from 2Q 2025). Profit margin: 0.6% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
New Risk • Feb 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 47% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.3% average weekly change). Market cap is less than US$100m (JP¥6.17b market cap, or US$39.9m).
分析記事 • Jan 08Improved Revenues Required Before Precision System Science Co., Ltd. (TSE:7707) Shares Find Their FeetWith a price-to-sales (or "P/S") ratio of 1.2x Precision System Science Co., Ltd. ( TSE:7707 ) may be sending bullish...
お知らせ • Dec 03Precision System Science Co., Ltd. to Report Q3, 2026 Results on May 15, 2026Precision System Science Co., Ltd. announced that they will report Q3, 2026 results on May 15, 2026
お知らせ • Dec 02Precision System Science Co., Ltd. to Report Q2, 2026 Results on Feb 16, 2026Precision System Science Co., Ltd. announced that they will report Q2, 2026 results on Feb 16, 2026
お知らせ • Oct 17Precision System Science Co., Ltd. to Report Q1, 2026 Results on Nov 14, 2025Precision System Science Co., Ltd. announced that they will report Q1, 2026 results on Nov 14, 2025
Reported Earnings • Oct 04Full year 2025 earnings released: JP¥9.20 loss per share (vs JP¥40.57 loss in FY 2024)Full year 2025 results: JP¥9.20 loss per share (improved from JP¥40.57 loss in FY 2024). Revenue: JP¥4.69b (up 18% from FY 2024). Net loss: JP¥253.0m (loss narrowed 77% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Aug 16Full year 2025 earnings released: JP¥9.20 loss per share (vs JP¥40.57 loss in FY 2024)Full year 2025 results: JP¥9.20 loss per share (improved from JP¥40.57 loss in FY 2024). Revenue: JP¥4.69b (up 18% from FY 2024). Net loss: JP¥253.0m (loss narrowed 77% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has fallen by 27% per year, which means it is performing significantly worse than earnings.
お知らせ • Aug 14Precision System Science Co., Ltd., Annual General Meeting, Sep 26, 2025Precision System Science Co., Ltd., Annual General Meeting, Sep 26, 2025.
お知らせ • Jun 29Precision System Science Co., Ltd. to Report Fiscal Year 2025 Results on Aug 14, 2025Precision System Science Co., Ltd. announced that they will report fiscal year 2025 results on Aug 14, 2025
Reported Earnings • May 21Third quarter 2025 earnings released: JP¥1.09 loss per share (vs JP¥2.53 profit in 3Q 2024)Third quarter 2025 results: JP¥1.09 loss per share (down from JP¥2.53 profit in 3Q 2024). Revenue: JP¥1.27b (up 36% from 3Q 2024). Net loss: JP¥30.0m (down 143% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings.
分析記事 • Apr 07Precision System Science Co., Ltd.'s (TSE:7707) 30% Dip In Price Shows Sentiment Is Matching RevenuesThe Precision System Science Co., Ltd. ( TSE:7707 ) share price has fared very poorly over the last month, falling by a...
お知らせ • Mar 07Precision System Science Co., Ltd. (TSE:7707) announces an Equity Buyback for 440,600 shares, for ¥100.46 million.Precision System Science Co., Ltd. (TSE:7707) announces a share repurchase program. Under the program, the company will repurchase up to 440,600 shares of its issued shares for a total of ¥100.46 million. The shares will be repurchased at a purchase price of ¥228 per share. The purpose of the program is to enhance shareholder returns and improve capital efficiency.
お知らせ • Mar 01Precision System Science Co., Ltd. to Report Q3, 2025 Results on May 15, 2025Precision System Science Co., Ltd. announced that they will report Q3, 2025 results on May 15, 2025
Reported Earnings • Feb 16Second quarter 2025 earnings released: JP¥2.79 loss per share (vs JP¥18.46 loss in 2Q 2024)Second quarter 2025 results: JP¥2.79 loss per share (improved from JP¥18.46 loss in 2Q 2024). Revenue: JP¥1.12b (up 19% from 2Q 2024). Net loss: JP¥77.0m (loss narrowed 85% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 48 percentage points per year, which is a significant difference in performance.
お知らせ • Dec 14Precision System Science Co., Ltd. to Report Q2, 2025 Results on Feb 14, 2025Precision System Science Co., Ltd. announced that they will report Q2, 2025 results on Feb 14, 2025
分析記事 • Nov 25Does Precision System Science (TSE:7707) Have A Healthy Balance Sheet?The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Reported Earnings • Oct 03Full year 2024 earnings released: JP¥40.57 loss per share (vs JP¥47.92 loss in FY 2023)Full year 2024 results: JP¥40.57 loss per share (improved from JP¥47.92 loss in FY 2023). Revenue: JP¥3.98b (down 25% from FY 2023). Net loss: JP¥1.12b (loss narrowed 15% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance.
分析記事 • Sep 04Optimistic Investors Push Precision System Science Co., Ltd. (TSE:7707) Shares Up 111% But Growth Is LackingPrecision System Science Co., Ltd. ( TSE:7707 ) shares have had a really impressive month, gaining 111% after a shaky...
お知らせ • Sep 04Precision System Science Co., Ltd. to Report Q1, 2025 Results on Nov 14, 2024Precision System Science Co., Ltd. announced that they will report Q1, 2025 results on Nov 14, 2024
Reported Earnings • Aug 19Full year 2024 earnings released: JP¥40.57 loss per share (vs JP¥47.92 loss in FY 2023)Full year 2024 results: JP¥40.57 loss per share (improved from JP¥47.92 loss in FY 2023). Revenue: JP¥3.98b (down 25% from FY 2023). Net loss: JP¥1.12b (loss narrowed 15% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 15Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. (TSE:7707) for ¥60 million.Shuji Tajima agreed to acquire Universal Bio Research Co., Ltd from Precision System Science Co., Ltd. (TSE:7707) for ¥60 million on August 14, 2024. A cash consideration of ¥60 million will be paid by the buyer. As part of consideration, ¥60 million is paid towards common equity of Universal Bio Research Co., Ltd. For the period ending June 30, 2024, Universal Bio Research Co., Ltd reported total revenue of ¥60.41 million, EBIT of ¥17.4 million and net income of ¥17.17 million. As of June 30, 2024, Universal Bio Research Co., Ltd reported total assets of ¥137.53 million and total common equity of ¥132.54 million. The expected completion of the transaction is December 31, 2024.
お知らせ • Aug 14Precision System Science Co., Ltd., Annual General Meeting, Sep 27, 2024Precision System Science Co., Ltd., Annual General Meeting, Sep 27, 2024.
分析記事 • Jul 18Precision System Science Co., Ltd. (TSE:7707) Shares Fly 30% But Investors Aren't Buying For GrowthThe Precision System Science Co., Ltd. ( TSE:7707 ) share price has done very well over the last month, posting an...
New Risk • Jul 18New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.6% average weekly change). Earnings have declined by 55% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥6.77b market cap, or US$43.3m).
Reported Earnings • May 21Third quarter 2024 earnings released: EPS: JP¥2.53 (vs JP¥6.51 loss in 3Q 2023)Third quarter 2024 results: EPS: JP¥2.53 (up from JP¥6.51 loss in 3Q 2023). Revenue: JP¥929.0m (down 14% from 3Q 2023). Net income: JP¥70.0m (up JP¥250.0m from 3Q 2023). Profit margin: 7.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 02Precision System Science Co., Ltd. to Report Q3, 2024 Results on May 15, 2024Precision System Science Co., Ltd. announced that they will report Q3, 2024 results on May 15, 2024
Reported Earnings • Feb 18Second quarter 2024 earnings released: JP¥18.46 loss per share (vs JP¥6.44 loss in 2Q 2023)Second quarter 2024 results: JP¥18.46 loss per share (further deteriorated from JP¥6.44 loss in 2Q 2023). Revenue: JP¥940.0m (down 41% from 2Q 2023). Net loss: JP¥510.0m (loss widened 187% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance.
New Risk • Feb 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (5.6% average weekly change). Market cap is less than US$100m (JP¥5.28b market cap, or US$35.2m).
お知らせ • Dec 08Precision System Science Co., Ltd. to Report Q2, 2024 Results on Feb 13, 2024Precision System Science Co., Ltd. announced that they will report Q2, 2024 results on Feb 13, 2024
Reported Earnings • Nov 18First quarter 2024 earnings released: JP¥7.85 loss per share (vs JP¥10.42 loss in 1Q 2023)First quarter 2024 results: JP¥7.85 loss per share (improved from JP¥10.42 loss in 1Q 2023). Revenue: JP¥1.07b (down 30% from 1Q 2023). Net loss: JP¥217.0m (loss narrowed 25% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance.
お知らせ • Sep 24Precision System Science Co., Ltd. to Report Q1, 2024 Results on Nov 14, 2023Precision System Science Co., Ltd. announced that they will report Q1, 2024 results on Nov 14, 2023
New Risk • Aug 16New major risk - Revenue and earnings growthEarnings have declined by 9.3% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.3% per year over the past 5 years. Minor Risk Market cap is less than US$100m (JP¥8.92b market cap, or US$61.4m).
Reported Earnings • Aug 16Full year 2023 earnings released: JP¥47.92 loss per share (vs JP¥1.63 profit in FY 2022)Full year 2023 results: JP¥47.92 loss per share (down from JP¥1.63 profit in FY 2022). Revenue: JP¥5.28b (down 29% from FY 2022). Net loss: JP¥1.32b (down JP¥1.37b from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 39 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 19Third quarter 2023 earnings released: JP¥6.51 loss per share (vs JP¥2.86 loss in 3Q 2022)Third quarter 2023 results: JP¥6.51 loss per share (further deteriorated from JP¥2.86 loss in 3Q 2022). Revenue: JP¥1.08b (down 42% from 3Q 2022). Net loss: JP¥180.0m (loss widened 128% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.
Reported Earnings • Feb 15Second quarter 2023 earnings released: JP¥6.44 loss per share (vs JP¥0.80 loss in 2Q 2022)Second quarter 2023 results: JP¥6.44 loss per share (further deteriorated from JP¥0.80 loss in 2Q 2022). Revenue: JP¥1.60b (down 7.2% from 2Q 2022). Net loss: JP¥178.0m (loss widened JP¥156.0m from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 10Precision System Science Co., Ltd. to Report Q2, 2023 Results on Feb 14, 2023Precision System Science Co., Ltd. announced that they will report Q2, 2023 results on Feb 14, 2023
Reported Earnings • Nov 16First quarter 2023 earnings released: JP¥10.42 loss per share (vs JP¥3.61 profit in 1Q 2022)First quarter 2023 results: JP¥10.42 loss per share (down from JP¥3.61 profit in 1Q 2022). Revenue: JP¥1.53b (down 18% from 1Q 2022). Net loss: JP¥288.0m (down 388% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Daisuke Ogiwara was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 13First quarter 2023 earnings released: JP¥10.42 loss per share (vs JP¥3.61 profit in 1Q 2022)First quarter 2023 results: JP¥10.42 loss per share (down from JP¥3.61 profit in 1Q 2022). Revenue: JP¥1.53b (down 18% from 1Q 2022). Net loss: JP¥288.0m (down 388% from profit in 1Q 2022). Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 06Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: JP¥1.63 (down from JP¥29.21 in FY 2021). Revenue: JP¥7.43b (down 20% from FY 2021). Net income: JP¥45.0m (down 94% from FY 2021). Profit margin: 0.6% (down from 8.6% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 7.1%. Earnings per share (EPS) also missed analyst estimates by 89%. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Sep 28Precision System Science Co., Ltd. to Report Q1, 2023 Results on Nov 11, 2022Precision System Science Co., Ltd. announced that they will report Q1, 2023 results on Nov 11, 2022
お知らせ • Aug 14Precision System Science Co., Ltd., Annual General Meeting, Sep 28, 2022Precision System Science Co., Ltd., Annual General Meeting, Sep 28, 2022.
Reported Earnings • Aug 14Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: JP¥1.63 (down from JP¥29.21 in FY 2021). Revenue: JP¥7.43b (down 20% from FY 2021). Net income: JP¥45.0m (down 94% from FY 2021). Profit margin: 0.6% (down from 8.6% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 7.1%. Earnings per share (EPS) also missed analyst estimates by 89%. Over the next year, revenue is forecast to grow 12%, compared to a 16% growth forecast for the pharmaceuticals industry in Japan. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 01Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to JP¥674, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 19x in the Life Sciences industry in Japan. Total returns to shareholders of 70% over the past three years.
Buying Opportunity • Jul 27Now 21% undervaluedOver the last 90 days, the stock is up 63%. The fair value is estimated to be JP¥878, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 12% in 2 years. Earnings is forecast to grow by 92% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 09Investor sentiment improved over the past weekAfter last week's 23% share price gain to JP¥575, the stock trades at a forward P/E ratio of 36x. Average forward P/E is 17x in the Life Sciences industry in Japan. Total returns to shareholders of 41% over the past three years.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 28% share price gain to JP¥463, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 17x in the Life Sciences industry in Japan. Total returns to shareholders of 9.1% over the past three years.
お知らせ • Jun 03Precision System Science Co., Ltd. to Report Fiscal Year 2022 Results on Aug 12, 2022Precision System Science Co., Ltd. announced that they will report fiscal year 2022 results on Aug 12, 2022
Reported Earnings • May 17Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: JP¥2.86 loss per share (down from JP¥3.87 profit in 3Q 2021). Revenue: JP¥1.87b (down 20% from 3Q 2021). Net loss: JP¥79.0m (down 174% from profit in 3Q 2021). Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 4.2% compared to a 4.4% decline forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Daisuke Ogiwara was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Buying Opportunity • Apr 07Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 3.8%. The fair value is estimated to be JP¥572, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 33% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 3.4% in 2 years. Earnings is forecast to grow by 11% in the next 2 years.
Price Target Changed • Mar 16Price target decreased to JP¥480Down from JP¥730, the current price target is provided by 1 analyst. New target price is 22% above last closing price of JP¥392. Stock is down 57% over the past year. The company is forecast to post earnings per share of JP¥14.50 for next year compared to JP¥29.21 last year.
お知らせ • Feb 27Precision System Science Co., Ltd. to Report Q3, 2022 Results on May 13, 2022Precision System Science Co., Ltd. announced that they will report Q3, 2022 results on May 13, 2022
Reported Earnings • Feb 16Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: JP¥0.80 loss per share (down from JP¥5.85 profit in 2Q 2021). Revenue: JP¥1.72b (down 30% from 2Q 2021). Net loss: JP¥22.0m (down 114% from profit in 2Q 2021). Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 7.6% compared to a 1.9% decline forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 16Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to JP¥425, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 41x in the Life Sciences industry in Asia. Total returns to shareholders of 18% over the past three years.
Valuation Update With 7 Day Price Move • Jan 28Investor sentiment improved over the past weekAfter last week's 29% share price gain to JP¥575, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 41x in the Life Sciences industry in Asia. Total returns to shareholders of 92% over the past three years.
Reported Earnings • Nov 15First quarter 2022 earnings released: EPS JP¥3.61 (vs JP¥7.43 in 1Q 2021)The company reported a poor first quarter result with weaker earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥1.87b (down 9.9% from 1Q 2021). Net income: JP¥100.0m (down 49% from 1Q 2021). Profit margin: 5.3% (down from 9.4% in 1Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Oct 05Full year 2021 earnings released: EPS JP¥29.21 (vs JP¥4.40 loss in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥9.30b (up 84% from FY 2020). Net income: JP¥795.0m (up JP¥909.0m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 123% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to JP¥670, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 61x in the Life Sciences industry in Asia. Total returns to shareholders of 53% over the past three years.
お知らせ • Aug 14Precision System Science Co., Ltd. (TSE:7707) announces an Equity Buyback for 200,000 shares, representing 0.72% for ¥100 million.Precision System Science Co., Ltd. (TSE:7707) announces a share repurchase program. Under the program, the company will repurchase up to 200,000 shares, representing 0.72% of its issued share capital (excluding treasury stock), at ¥500 per share, for ¥100 million. The purpose of the program is to enhance shareholder returns and to increase the agility of capital policies, and providing incentives for the sustainable improvement of the company's corporate value. The program will run until October 29, 2021. As of June 30, 2021, the company had 27,666,900 shares in issue (excluding treasury stock) and 86 shares in treasury.
Reported Earnings • May 17Third quarter 2021 earnings released: EPS JP¥3.87 (vs JP¥0.42 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥2.34b (up 74% from 3Q 2020). Net income: JP¥107.0m (up JP¥96.0m from 3Q 2020). Profit margin: 4.6% (up from 0.8% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 120% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to JP¥888, the stock is trading at a trailing P/E ratio of 52.8x, down from the previous P/E ratio of 71.7x. This compares to an average P/E of 41x in the Life Sciences industry in Japan. Total returns to shareholders over the past three years are 51%.
Is New 90 Day High Low • Feb 18New 90-day low: JP¥888The company is down 30% from its price of JP¥1,270 on 20 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is up 4.0% over the same period.
Reported Earnings • Feb 14Second quarter 2021 earnings released: EPS JP¥5.85 (vs JP¥3.63 loss in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: JP¥2.45b (up 121% from 2Q 2020). Net income: JP¥159.0m (up JP¥253.0m from 2Q 2020). Profit margin: 6.5% (up from net loss in 2Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 03Precision System Science Co., Ltd. to Report Q2, 2021 Results on Feb 12, 2021Precision System Science Co., Ltd. announced that they will report Q2, 2021 results on Feb 12, 2021
Is New 90 Day High Low • Dec 22New 90-day low: JP¥948The company is down 36% from its price of JP¥1,473 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 18% over the same period.
Is New 90 Day High Low • Dec 07New 90-day low: JP¥1,050The company is down 33% from its price of JP¥1,571 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Life Sciences industry, which is down 8.0% over the same period.
Price Target Changed • Dec 01Price target raised to JP¥660Up from JP¥400, the current price target is provided by 1 analyst. The new target price is 43% below the current share price of JP¥1,168. As of last close, the stock is up 199% over the past year.
お知らせ • Oct 10Precision System Science Co., Ltd. to Report Q1, 2021 Results on Nov 13, 2020Precision System Science Co., Ltd. announced that they will report Q1, 2021 results on Nov 13, 2020
